vs

Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

COLONY BANKCORP INC is the larger business by last-quarter revenue ($39.9M vs $32.6M, roughly 1.2× RxSight, Inc.). COLONY BANKCORP INC runs the higher net margin — 20.6% vs -28.1%, a 48.6% gap on every dollar of revenue. Over the past eight quarters, COLONY BANKCORP INC's revenue compounded faster (19.6% CAGR vs 5.1%).

Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CBAN vs RXST — Head-to-Head

Bigger by revenue
CBAN
CBAN
1.2× larger
CBAN
$39.9M
$32.6M
RXST
Higher net margin
CBAN
CBAN
48.6% more per $
CBAN
20.6%
-28.1%
RXST
Faster 2-yr revenue CAGR
CBAN
CBAN
Annualised
CBAN
19.6%
5.1%
RXST

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBAN
CBAN
RXST
RXST
Revenue
$39.9M
$32.6M
Net Profit
$8.2M
$-9.2M
Gross Margin
77.5%
Operating Margin
-34.8%
Net Margin
20.6%
-28.1%
Revenue YoY
-18.9%
Net Profit YoY
24.1%
-54.1%
EPS (diluted)
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAN
CBAN
RXST
RXST
Q1 26
$39.9M
Q4 25
$36.9M
$32.6M
Q3 25
$32.8M
$30.3M
Q2 25
$32.5M
$33.6M
Q1 25
$30.0M
$37.9M
Q4 24
$30.8M
$40.2M
Q3 24
$28.6M
$35.3M
Q2 24
$27.9M
$34.9M
Net Profit
CBAN
CBAN
RXST
RXST
Q1 26
$8.2M
Q4 25
$-9.2M
Q3 25
$5.8M
$-9.8M
Q2 25
$8.0M
$-11.8M
Q1 25
$6.6M
$-8.2M
Q4 24
$-5.9M
Q3 24
$5.6M
$-6.3M
Q2 24
$5.5M
$-6.1M
Gross Margin
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Operating Margin
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
25.9%
-34.8%
Q3 25
22.2%
-40.1%
Q2 25
30.9%
-41.6%
Q1 25
27.6%
-28.2%
Q4 24
28.8%
-21.5%
Q3 24
24.6%
-26.1%
Q2 24
24.8%
-23.9%
Net Margin
CBAN
CBAN
RXST
RXST
Q1 26
20.6%
Q4 25
-28.1%
Q3 25
17.7%
-32.4%
Q2 25
24.6%
-35.0%
Q1 25
22.0%
-21.6%
Q4 24
-14.8%
Q3 24
19.7%
-17.9%
Q2 24
19.6%
-17.4%
EPS (diluted)
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
$0.42
$-0.22
Q3 25
$0.33
$-0.24
Q2 25
$0.46
$-0.29
Q1 25
$0.38
$-0.20
Q4 24
$0.43
$-0.14
Q3 24
$0.32
$-0.16
Q2 24
$0.31
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAN
CBAN
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$295.8M
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$380.4M
$275.7M
Total Assets
$3.7B
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAN
CBAN
RXST
RXST
Q1 26
$295.8M
Q4 25
$228.1M
Q3 25
$227.5M
Q2 25
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
Q3 24
$237.1M
Q2 24
$233.3M
Total Debt
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
$258.1M
Q3 25
Q2 25
Q1 25
Q4 24
$248.0M
Q3 24
Q2 24
Stockholders' Equity
CBAN
CBAN
RXST
RXST
Q1 26
$380.4M
Q4 25
$375.9M
$275.7M
Q3 25
$302.3M
$276.0M
Q2 25
$293.9M
$278.0M
Q1 25
$286.9M
$279.3M
Q4 24
$278.7M
$281.2M
Q3 24
$276.1M
$277.3M
Q2 24
$264.7M
$275.2M
Total Assets
CBAN
CBAN
RXST
RXST
Q1 26
$3.7B
Q4 25
$3.7B
$311.8M
Q3 25
$3.2B
$308.5M
Q2 25
$3.1B
$309.0M
Q1 25
$3.2B
$313.0M
Q4 24
$3.1B
$318.6M
Q3 24
$3.1B
$310.5M
Q2 24
$3.0B
$305.5M
Debt / Equity
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
0.69×
Q3 25
Q2 25
Q1 25
Q4 24
0.89×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAN
CBAN
RXST
RXST
Operating Cash FlowLast quarter
$-1.1M
Free Cash FlowOCF − Capex
$-2.3M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
$-5.5M
$-1.1M
Q3 25
$14.4M
$-1.2M
Q2 25
$15.8M
$-4.4M
Q1 25
$17.9M
$-8.8M
Q4 24
$23.4M
$-4.3M
Q3 24
$20.5M
$650.0K
Q2 24
$1.1M
$-4.0M
Free Cash Flow
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
$-6.9M
$-2.3M
Q3 25
$14.1M
$-1.8M
Q2 25
$15.8M
$-5.9M
Q1 25
$17.6M
$-9.4M
Q4 24
$22.3M
$-5.1M
Q3 24
$20.2M
$-453.0K
Q2 24
$990.0K
$-5.5M
FCF Margin
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
-18.7%
-6.9%
Q3 25
42.9%
-5.8%
Q2 25
48.5%
-17.6%
Q1 25
58.7%
-24.8%
Q4 24
72.5%
-12.7%
Q3 24
70.6%
-1.3%
Q2 24
3.5%
-15.9%
Capex Intensity
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
3.7%
3.5%
Q3 25
1.1%
1.9%
Q2 25
0.3%
4.6%
Q1 25
1.2%
1.5%
Q4 24
3.5%
2.1%
Q3 24
1.0%
3.1%
Q2 24
0.5%
4.4%
Cash Conversion
CBAN
CBAN
RXST
RXST
Q1 26
Q4 25
Q3 25
2.48×
Q2 25
1.99×
Q1 25
2.71×
Q4 24
Q3 24
3.64×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAN
CBAN

Net Interest Income$29.2M73%
Noninterest Income$10.7M27%

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons